Characterization of low dose streptozotocin-induced progressive diabetes in mice

Environmental Toxicology and Pharmacology

Volumn 9, Issue 3, 2001, Pages 71-78

  Ito, Mikio ^a   Kondo, Yoichi ^a   Nakatani, Akiko ^a   Hayashi, Koji ^a   Naruse, Atsuhiko ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Mouse; Non insulin dependent; Slowly progressive diabetes; Streptozotocin

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; IMMUNOCOMPETENT CELL; INSULIN BLOOD LEVEL; INSULIN RESPONSE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

EID: 0035129561     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(00)00064-8     Document Type: Article

References (17)

1. Insulin secretion in neonatally streptozotocin-injected mice
2. Long-term diabetogenic effect of streptozotocin in rats
3. Streptozotocin induced diabetes in the mouse and guinea pig
4. Characterization of new oral antidiabetic agent CS-045
5. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes
6. Isolation and characterization of streptozotocin
7. New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin
8. Studies of the diabetogenic action of streptozotocin
9. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response
10. Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15
11. Studies on the diabetogenic action of streptozotocin (NSC-37917)
12. Drugs producing diabetes through damage of insulin secreting cells
13. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations
14. Mode of action of three structurally different hypoglycemic agents: A comparative study
15. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model
16. Beta-cell proliferation in normal and streptozotocin-treated newborn rats; site, dynamics and capacity
17. Long-term exposure of rat pancreatic islets fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle